These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38163762)

  • 21. Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values.
    Haffner S; von Laue N; Wirth S; Thürmann PA
    Drug Saf; 2005; 28(5):453-64. PubMed ID: 15853446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective identification and causality evaluation of suspected adverse drug reactions in neonates.
    Roberts EK; Hawcutt DB; Turner MA
    Br J Clin Pharmacol; 2021 Mar; 87(3):1541-1546. PubMed ID: 32696451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.
    Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A
    Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychiatric adverse drug reactions in the paediatric population.
    Ekhart C; Vries T; Hunsel FV
    Arch Dis Child; 2020 Aug; 105(8):749-755. PubMed ID: 32060030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
    Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Italian monitoring registries: a tool for a safer use of innovative drugs? Data from the national pharmacovigilance system.
    Magro L; Arzenton E; Moretti U; Sottosanti L; Potenza S; Leone R
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):69-75. PubMed ID: 27875920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register.
    Wallerstedt SM; Brunlöf G; Sundström A
    Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
    't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
    Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paediatric drug use with focus on off-label prescriptions at Swedish hospitals - a nationwide study.
    Kimland E; Nydert P; Odlind V; Böttiger Y; Lindemalm S
    Acta Paediatr; 2012 Jul; 101(7):772-8. PubMed ID: 22404126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Off-label use of medicines in paediatric inpatients at an Australian teaching hospital.
    Ballard CD; Peterson GM; Thompson AJ; Beggs SA
    J Paediatr Child Health; 2013 Jan; 49(1):38-42. PubMed ID: 23279160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription Pattern Monitoring and Off-label Use of Medicines in the Pediatric Department at Tertiary Care Teaching Hospital.
    Pandey S; Yadav CK; Ghimire P; Shrestha AC
    Kathmandu Univ Med J (KUMJ); 2020 Oct.-Dec.; 18(72):367-371. PubMed ID: 34165093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Children and ADRs (Adverse Drug Reactions).
    Napoleone E
    Ital J Pediatr; 2010 Jan; 36():4. PubMed ID: 20180963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden.
    Ufer M; Kimland E; Bergman U
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):147-52. PubMed ID: 15072113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety profile of methotrexate used off-label in ectopic pregnancy: an active monitoring study based on a Chinese hospital pharmacovigilance system.
    Wang L; Cai C; Huang L; Shi D; Chen Q; Chen Y; Yu W
    Curr Med Res Opin; 2024 Jan; 40(1):35-42. PubMed ID: 37975718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014.
    Tukayo BLA; Sunderland B; Parsons R; Czarniak P
    PLoS One; 2020; 15(1):e0227687. PubMed ID: 31935254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Retrospective Analysis of Spontaneous Adverse Drug Reactions Reports Relating to Paediatric Patients.
    Rosli R; Ming LC; Abd Aziz N; Manan MM
    PLoS One; 2016; 11(6):e0155385. PubMed ID: 27249414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unlicensed and off label drug use in paediatric wards: prospective study.
    Turner S; Longworth A; Nunn AJ; Choonara I
    BMJ; 1998 Jan; 316(7128):343-5. PubMed ID: 9487167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data.
    Dipasquale V; Cicala G; Laganà F; Cutroneo P; Felicetti P; Potenza S; Trimarchi G; Spina E; Romano C
    Expert Opin Drug Saf; 2022 Jan; 21(1):127-132. PubMed ID: 34494498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.